Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Roos

Showing results (71-80 of 271) with videos related to

Pageof 28
Sort By:
Selective Cancer Therapeutics|January 1, 1991
Reduction by norepinephrine of the side effects induced by combined hepatic arterial administration of degradable strach microspheres and adriamycin in rats with a liver adenocarcinomaB Jakobsson, H Teder, G Roos, et al.
Anticancer Research|November 1, 1991
Ki-67 as a marker for cell cycle regulation by interferonD Lundblad, G Landberg, G Roos, et al.
Scandinavian Journal of Urology and Nephrology|December 1, 1996
Proliferating cell nuclear antigen expression in renal cell carcinoma. Prognostic implicationsP Larsson, G Roos, R Stenling, et al.
Selective Cancer Therapeutics|January 1, 1990
Decrease of liver energy charge, ATP and glutathione at concomitant intraarterial administration of adriamycin and degradable starch microspheres in ratI A el Hag, G Roos, U Stenram
Diseases of the Colon and Rectum|December 1, 1989
DNA content and mucosal dysplasia in ulcerative colitis. Flow cytometric analysis in patients with dysplastic or indefinite morphologic changes in the colorectal mucosaJ Rutegård, L Ahsgren, R Stenling, et al.
Acta Medica Scandinavica|May 1, 1982
Melphalan-related leukemia in multiple myelomaA Wahlin, G Roos, O Rudolphi, et al.
European Journal of Haematology|March 1, 1989
Simultaneous presentation of relapsing non-Hodgkin's lymphoma and Hodgkin's diseaseP Lenner, G Roos, M Hedenus, et al.
European Journal of Haematology|May 1, 1993
Prognostic significance of serum lactic dehydrogenase levels and fraction of S-phase cells in non-Hodgkin lymphomasJ Lindh, P Lenner, B Osterman, et al.
British Journal of Cancer|June 5, 2003
Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarrayY Hedberg, B Ljungberg, G Roos, et al.
Scandinavian Journal of Urology and Nephrology|June 1, 1994
Proliferation of human renal cell carcinoma studied with in vivo iododeoxyuridine labelling and immunohistochemistryP Larsson, G Roos, R Stenling, et al.
Pageof 28

Showing results (71-80 of 271) with videos related to

Sort By:
Pageof 28
Selective Cancer Therapeutics|January 1, 1991
Reduction by norepinephrine of the side effects induced by combined hepatic arterial administration of degradable strach microspheres and adriamycin in rats with a liver adenocarcinomaB Jakobsson, H Teder, G Roos, et al.
Anticancer Research|November 1, 1991
Ki-67 as a marker for cell cycle regulation by interferonD Lundblad, G Landberg, G Roos, et al.
Scandinavian Journal of Urology and Nephrology|December 1, 1996
Proliferating cell nuclear antigen expression in renal cell carcinoma. Prognostic implicationsP Larsson, G Roos, R Stenling, et al.
Selective Cancer Therapeutics|January 1, 1990
Decrease of liver energy charge, ATP and glutathione at concomitant intraarterial administration of adriamycin and degradable starch microspheres in ratI A el Hag, G Roos, U Stenram
Diseases of the Colon and Rectum|December 1, 1989
DNA content and mucosal dysplasia in ulcerative colitis. Flow cytometric analysis in patients with dysplastic or indefinite morphologic changes in the colorectal mucosaJ Rutegård, L Ahsgren, R Stenling, et al.
Acta Medica Scandinavica|May 1, 1982
Melphalan-related leukemia in multiple myelomaA Wahlin, G Roos, O Rudolphi, et al.
European Journal of Haematology|March 1, 1989
Simultaneous presentation of relapsing non-Hodgkin's lymphoma and Hodgkin's diseaseP Lenner, G Roos, M Hedenus, et al.
European Journal of Haematology|May 1, 1993
Prognostic significance of serum lactic dehydrogenase levels and fraction of S-phase cells in non-Hodgkin lymphomasJ Lindh, P Lenner, B Osterman, et al.
British Journal of Cancer|June 5, 2003
Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarrayY Hedberg, B Ljungberg, G Roos, et al.
Scandinavian Journal of Urology and Nephrology|June 1, 1994
Proliferation of human renal cell carcinoma studied with in vivo iododeoxyuridine labelling and immunohistochemistryP Larsson, G Roos, R Stenling, et al.
Pageof 28